Monday, December 23, 2024
HomeTagsCSPC Megalith Biopharmaceutical

CSPC Megalith Biopharmaceutical

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)

Corbus Pharmaceuticals Holdings, Inc, a precision oncology company, announced that it has entered into an exclusive licensing agreement with CSPC Megalith Biopharmaceutical Co., Ltd,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics